(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three most active and biggest winners today are Sorrento Therapeutics, Futu Holdings, and BeiGene.

Rank Financial Asset Price Change Updated (EST)
1 Sorrento Therapeutics (SRNE) 2.09 24.11% 2022-06-21 14:46:23
2 Futu Holdings (FUTU) 51.76 16.09% 2022-06-21 14:48:53
3 BeiGene (BGNE) 151.79 14.87% 2022-06-21 14:47:56
4 DAQO New Energy (DQ) 66.82 14.34% 2022-06-21 14:58:42
5 Coinbase (COIN) 57.63 12.52% 2022-06-21 14:53:52
6 Leju Holdings Limited (LEJU) 3.43 12.46% 2022-06-20 19:07:07
7 ImmunoGen (IMGN) 4.11 10.78% 2022-06-21 14:57:07
8 Riot Blockchain (RIOT) 5.15 10.75% 2022-06-21 14:50:11
9 Sundial Growers (SNDL) 0.35 10.72% 2022-06-21 11:20:30
10 Tesla (TSLA) 719.35 10.62% 2022-06-21 14:46:42

The three most active and biggest losers today are Mesa Royalty Trust, Ecopetrol S.A., and MV Oil Trust Units of Beneficial Interests.

Rank Financial Asset Price Change Updated (EST)
1 Mesa Royalty Trust (MTR) 14.96 -14.51% 2022-06-21 03:46:14
2 Ecopetrol S.A. (EC) 12.19 -10.93% 2022-06-21 14:54:14
3 MV Oil Trust Units of Beneficial Interests (MVO) 9.32 -9.51% 2022-06-21 05:06:14
4 Laredo Petroleum (LPI) 81.47 -8.74% 2022-06-20 19:41:14
5 Fresenius Medical Care AG (FMS) 23.57 -8.64% 2022-06-21 14:54:45
6 Matador Resources Company (MTDR) 51.20 -8.64% 2022-06-21 03:12:05
7 McEwen Mining (MUX) 0.50 -7.95% 2022-06-21 04:44:13
8 Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (LND) 5.43 -7.34% 2022-06-20 19:14:13
9 Ebix (EBIX) 15.69 -5.66% 2022-06-21 14:57:20
10 Natural Grocers by Vitamin Cottage (NGVC) 15.64 -5.38% 2022-06-21 07:48:13

Most Active Winners today

1. Sorrento Therapeutics (SRNE) – 24.11%

Sorrento Therapeutics, Inc., is a biopharma company at clinical stage. It develops treatments for neurodegenerative, autoimmune, and cancer. The company operates in two segments: Sorrento Therapeutics, and Scilex. It offers cancer therapies by using its G-MAB proprietary antibody library and targeted delivery modes. These include CAR-T, dimeric antigen T-cell treatment (CAR-T), and antibody drug conjugates as well as bispecific approaches. Sofusa is a technology to deliver biologics directly into your lymphatic system. The company is also developing anti-CD38 CAR–T therapies for multiple myeloma and amyloidosis. It also develops resiniferatoxin (a non-opioid TRPV1 antagonist neurotoxin) for treatment of osteoarthritis and late-stage cancer; ZTlido (a lidocaine delivery method for postherpetic nerve pain); and ZTibo (a lidocaine delivery device for treatment of postherpetic narcolepsy). SEMDEXA is an injectable viscous jelly formulation that the company has been developing. It’s currently in Phase III clinical trials for sciatica. SP-103 is an investigational, non-aqueous, lidocaine-based topical system in clinical development. SmartPharm Therapeutics Inc. is one of its partners in developing a gene-encoded vaccine against COVID-19. Celularity, Inc. initiated Phase I/II clinical studies, which included up to 86 patients. Mount Sinai Health System was involved in the development of COVI-SHIELD, an anti-SARS treatment. It also has a preclinical agreement with Galveston’s University of Texas Medical Branch for testing Sorrento’s COVID-19 therapeutic products candidates. It was established in San Diego in 2006.

NASDAQ ended the session with Sorrento Therapeutics jumping 24.11% to $2.09 on Tuesday, following the last session’s upward trend. NASDAQ rose 2.51% to $11,069.30, following the last session’s upward trend on what was an all-around positive trend trading session today.

Volume

Today’s last reported volume for Sorrento Therapeutics is 22637300 which is 152.97% above its average volume of 8948300.

Sorrento Therapeutics’s last close was $1.68, 84.82% under its 52-week high of $11.07.

Sorrento Therapeutics’s Sales

Sorrento Therapeutics’s sales growth is 29% for the ongoing quarter and 85.1% for the next. The company’s growth estimates for the current quarter is a negative 1700% and positive 77.2% for the next.

Sorrento Therapeutics’s Revenue

Year-on-year quarterly revenue growth grew by 13.7%, now sitting on 52.9M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Sorrento Therapeutics’s stock is considered to be oversold (<=20).

Sorrento Therapeutics’s Stock Yearly Top and Bottom Value

Sorrento Therapeutics’s stock is valued at $2.09 at 17:32 EST, way under its 52-week high of $11.07 and way higher than its 52-week low of $1.15.

Sorrento Therapeutics’s Moving Average

Sorrento Therapeutics’s worth is way above its 50-day moving average of $1.70 and way below its 200-day moving average of $4.40.

More news about Sorrento Therapeutics.

2. Futu Holdings (FUTU) – 16.09%

Futu Holdings Limited is a digital brokerage company that offers wealth management and digital brokerage services in Hong Kong, China and the United States. It offers investment services such as trade execution and margin finance that allow you to trade stocks, warrants and options in different markets. Wealth management services also offer various top fund products including fixed income and money market funds. The company’s securities lending and margin financing provides cross-market, real-time securities-backed financing; market data and information services. It was established in Admiralty in Hong Kong in 2011.

NASDAQ ended the session with Futu Holdings rising 16.09% to $51.76 on Tuesday while NASDAQ jumped 2.51% to $11,069.30.

Volume

Today’s last reported volume for Futu Holdings is 8375660 which is 79.82% above its average volume of 4657650.

Futu Holdings’s last close was $44.58, 75.43% under its 52-week high of $181.44.

The company’s growth estimates for the current quarter and the next is 556.2% and 320%, respectively.

Futu Holdings’s Revenue

Year-on-year quarterly revenue growth grew by 37.9%, now sitting on 6.74B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Futu Holdings’s stock is considered to be oversold (<=20).

Futu Holdings’s Stock Yearly Top and Bottom Value

Futu Holdings’s stock is valued at $51.76 at 17:32 EST, way below its 52-week high of $181.44 and way above its 52-week low of $21.23.

Futu Holdings’s Moving Average

Futu Holdings’s worth is way higher than its 50-day moving average of $34.76 and above its 200-day moving average of $51.59.

More news about Futu Holdings.

3. BeiGene (BGNE) – 14.87%

BeiGene, Ltd. is a biotechnology company at the commercial stage. It develops and markets immuno-oncology and molecularly targeted cancer therapies in China, the United States, as well internationally. BRUKINSA is used to treat R/R classic Hodgkin’s lymphoma. Tislelizumab is used to treat R/R classic Hodgkin’s lymphoma. REVLIMID is used to treat multiple myeloma. KYPROLIS can be used to treat multiple myeloma. BLINCYTO treats acute lymphocytic encephalopathy. SYLVANT, which treat idiopathic multifocentric castleman; and QARZIBA, to deal with neuroblastoma, Zanubrutinib is a BTK inhibitor that treats various lymphomas. Tislelizumab is an anti-PD-1 anti-cancer antibody to treat many solid and hematological tumors. Pamiparib to treat multiple myeloma; KYPROLIS to treat multiple myeloma; BLINCYTO to treat acute lymphocytic leukemia; SYLVANT to treat idiopathic multicentric castleman disease; and to treatment of solid tumors. BGB – A333 is a PD-1 inhibitor that can be used to treat different solid tumors. BGB – A1217 is a TIGIT inhibitor that can also treat certain solid tumors. BGB – 11417, a small molecule Bcl-2 inhibitor to deal with mature B-cell malignancies. BGB – A445, an OX40 agonist anti-tumor antibody, will also be available in clinical stages. Celgene Corporation, Merck KGaA, Mirati Therapeutics, Inc., BioAtla, Inc., Zymeworks, Inc., Atreca Inc., IGM Biosciences, Inc., and Hutchison China MediTech Limited have collaborated with the company. BeiGene, Ltd., was established in Beijing, People’s Republic of China in 2010.

NASDAQ ended the session with BeiGene rising 14.87% to $151.79 on Tuesday, after two successive sessions in a row of losses. NASDAQ rose 2.51% to $11,069.30, following the last session’s upward trend on what was an all-around positive trend trading session today.

Volume

Today’s last reported volume for BeiGene is 753047 which is 169.11% above its average volume of 279824.

BeiGene’s last close was $132.14, 69.02% below its 52-week high of $426.56.

BeiGene’s Sales

BeiGene’s sales growth is 226.8% for the current quarter and a decline by 57.9% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 1.7% and a negative 788.4%, respectively.

BeiGene’s Revenue

Year-on-year quarterly revenue growth grew by 113.8%, now sitting on 1.18B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

BeiGene’s stock is considered to be overbought (>=80).

BeiGene’s Stock Yearly Top and Bottom Value

BeiGene’s stock is valued at $151.79 at 17:32 EST, way below its 52-week high of $426.56 and way higher than its 52-week low of $118.18.

BeiGene’s Moving Average

BeiGene’s value is above its 50-day moving average of $150.90 and way under its 200-day moving average of $252.61.

More news about BeiGene.

4. DAQO New Energy (DQ) – 14.34%

Daqo New Energy Corp. and its subsidiaries manufactures, sells, and distributes photovoltaic products to the People’s Republic of China. The company offers ready-to use polysilicon that is packaged according to crucible pulling, stacking and solidification requirements. Mega Stand International Limited was the company’s previous name. In August 2009, Daqo New Energy Corp. took over that title. Daqo New Energy Corp. is located in Wanzhou in the People’s Republic of China.

NYSE ended the session with DAQO New Energy rising 14.34% to $66.82 on Tuesday, following the last session’s upward trend. NYSE rose 2.25% to $14,414.25, after two successive sessions in a row of losses, on what was an all-around bullish trend exchanging session today.

Volume

Today’s last reported volume for DAQO New Energy is 3411570 which is 157.2% above its average volume of 1326420.

DAQO New Energy’s last close was $58.44, 35.41% below its 52-week high of $90.48.

DAQO New Energy’s Sales

DAQO New Energy’s sales growth is 182% for the ongoing quarter and 106.9% for the next. The company’s growth estimates for the present quarter and the next is 377.1% and 240.7%, respectively.

DAQO New Energy’s Revenue

Year-on-year quarterly revenue growth grew by 399.9%, now sitting on 2.7B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

DAQO New Energy’s stock is considered to be oversold (<=20).

DAQO New Energy’s Stock Yearly Top and Bottom Value

DAQO New Energy’s stock is valued at $66.82 at 17:32 EST, way under its 52-week high of $90.48 and way above its 52-week low of $32.20.

DAQO New Energy’s Moving Average

DAQO New Energy’s value is way higher than its 50-day moving average of $47.03 and way above its 200-day moving average of $50.21.

More news about DAQO New Energy.

5. Coinbase (COIN) – 12.52%

NASDAQ ended the session with Coinbase jumping 12.52% to $57.63 on Tuesday, after two consecutive sessions in a row of gains. NASDAQ rose 2.51% to $11,069.30, following the last session’s upward trend on what was an all-around positive trend exchanging session today.

Volume

Today’s last reported volume for Coinbase is 15097000 which is 34.48% above its average volume of 11225500.

Coinbase’s last close was $51.22, 86.12% below its 52-week high of $368.90.

The company’s growth estimates for the current quarter and the next is a negative 97.7% and a negative 101.2%, respectively.

Coinbase’s Revenue

Year-on-year quarterly revenue growth grew by 327.1%, now sitting on 7.84B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Coinbase’s stock is considered to be overbought (>=80).

Coinbase’s Stock Yearly Top and Bottom Value

Coinbase’s stock is valued at $57.63 at 17:32 EST, way below its 52-week high of $368.90 and way above its 52-week low of $40.83.

Coinbase’s Moving Average

Coinbase’s value is way below its 50-day moving average of $107.90 and way under its 200-day moving average of $210.61.

More news about Coinbase.

6. Leju Holdings Limited (LEJU) – 12.46%

Through its subsidiaries, Leju Holdings Limited provides O2O real estate services online in China. Through its online platform which includes 386 cities, as well as various apps, the company provides real estate ecommerce, online advertising and online listing. The company also has official accounts on Weixin (a social media platform) and Weibo (a microblog). The company also offers discount coupons, online property viewing and physical property visits. It facilitates pre-sale customer service and home furnishing transactions via its new residential property platform. It also sells advertising on SINA’s new residential properties, home furnishing websites and serves as an agent for advertising that is sold to home-furnishing suppliers and real estate developers. The company also offers services for individual property sellers and fee-based online listing to agents. Leju Holdings Limited, which was established in 2013, is located in Beijing (the People’s Republic of China).

NYSE ended the session with Leju Holdings Limited rising 12.46% to $3.43 on Tuesday, after two consecutive sessions in a row of gains. NYSE jumped 2.25% to $14,414.25, after two successive sessions in a row of losses, on what was an all-around positive trend exchanging session today.

Volume

Today’s last reported volume for Leju Holdings Limited is 26779 which is 56.98% below its average volume of 62260.

Leju Holdings Limited’s last close was $3.43, 83.27% below its 52-week high of $20.50.

Leju Holdings Limited’s Revenue

Year-on-year quarterly revenue growth declined by 49.4%, now sitting on 534.12M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Leju Holdings Limited’s stock is considered to be oversold (<=20).

Leju Holdings Limited’s Stock Yearly Top and Bottom Value

Leju Holdings Limited’s stock is valued at $3.43 at 17:32 EST, way below its 52-week high of $20.50 and way above its 52-week low of $2.80.

Leju Holdings Limited’s Moving Average

Leju Holdings Limited’s value is way under its 50-day moving average of $4.22 and way under its 200-day moving average of $8.02.

More news about Leju Holdings Limited.

7. ImmunoGen (IMGN) – 10.78%

ImmunoGen, Inc., is a biotech company in clinical stage. It develops ADC therapies for cancer. Mirvetuximab Soravtansine is an ADC which targets folate receptor alpha and is currently in Phase III clinical trials for treatment of platinum resistant ovarian carcinoma. IMGN632, a CD123 targeting ADC, is also in Phase I clinical trials for AML and blastic Plasmacytoid Dendritic Cell Neoplasm. Preclinical programs include IMGC936, an ADC that is being developed in collaboration with MacroGenics, Inc. ImmunoGen, Inc. collaborates with Roche, Amgen/Oxford BioTherapeutics, Bayer HealthCare AG, Eli Lilly and Company, Novartis Institutes for BioMedical Research, Inc., CytomX Therapeutics, Inc., Fusion Pharmaceuticals Inc., Debiopharm International SA, Jazz Pharmaceuticals Ireland Limited, and MacroGenics, Inc.

NASDAQ ended the session with ImmunoGen jumping 10.78% to $4.11 on Tuesday while NASDAQ rose 2.51% to $11,069.30.

Volume

Today’s last reported volume for ImmunoGen is 3789980 which is 0.07% below its average volume of 3792700.

ImmunoGen’s last close was $3.71, 52.25% below its 52-week high of $7.77.

ImmunoGen’s Sales

ImmunoGen’s sales growth is a negative 4.5% for the present quarter and 39.7% for the next. The company’s growth estimates for the present quarter and the next is a negative 46.7% and a negative 38.9%, respectively.

ImmunoGen’s Revenue

Year-on-year quarterly revenue growth declined by 67.4%, now sitting on 69.86M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

ImmunoGen’s stock is considered to be oversold (<=20).

ImmunoGen’s Stock Yearly Top and Bottom Value

ImmunoGen’s stock is valued at $4.11 at 17:32 EST, way below its 52-week high of $7.77 and way above its 52-week low of $3.36.

ImmunoGen’s Moving Average

ImmunoGen’s worth is under its 50-day moving average of $4.46 and way below its 200-day moving average of $5.53.

More news about ImmunoGen.

8. Riot Blockchain (RIOT) – 10.75%

NASDAQ ended the session with Riot Blockchain rising 10.75% to $5.15 on Tuesday while NASDAQ jumped 2.51% to $11,069.30.

Volume

Today’s last reported volume for Riot Blockchain is 16367700 which is 53.46% above its average volume of 10665200.

Riot Blockchain’s last close was $4.65, 89.95% below its 52-week high of $46.28.

Riot Blockchain’s Sales

Riot Blockchain’s sales growth is 1759.8% for the current quarter and 411.3% for the next. The company’s growth estimates for the current quarter and the next is 212.5% and 444.4%, respectively.

Riot Blockchain’s Revenue

Year-on-year quarterly revenue growth grew by 2532.3%, now sitting on 127.64M for the twelve trailing months.

Riot Blockchain’s Stock Yearly Top and Bottom Value

Riot Blockchain’s stock is valued at $5.15 at 17:32 EST, way below its 52-week low of $6.25.

Riot Blockchain’s Moving Average

Riot Blockchain’s value is way under its 50-day moving average of $15.16 and way under its 200-day moving average of $24.25.

More news about Riot Blockchain.

9. Sundial Growers (SNDL) – 10.72%

Sundial Growers Inc. is involved in production, distribution and sales of marijuana products for adult-use markets. It also produces, distributes, and sells ornamental plants in the United Kingdom. It sells its products under the Top Leaf and Sundial Cannabis brands. Sundial Growers Inc. is an American company that was founded in 2006. Its headquarters are located in Calgary, Canada.

NASDAQ ended the session with Sundial Growers jumping 10.72% to $0.35 on Tuesday while NASDAQ rose 2.51% to $11,069.30.

Volume

Today’s last reported volume for Sundial Growers is 72205700 which is 29.74% below its average volume of 102778000.

Sundial Growers’s last close was $0.31, 78.97% under its 52-week high of $1.49.

Sundial Growers’s Sales

Sundial Growers’s sales growth is 129.8% for the ongoing quarter and 1461.8% for the next. The company’s growth estimates for the ongoing quarter and the next is 100% and 100%, respectively.

Sundial Growers’s Revenue

Year-on-year quarterly revenue growth grew by 11.7%, now sitting on 47.26M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Sundial Growers’s stock is considered to be oversold (<=20).

Sundial Growers’s Stock Yearly Top and Bottom Value

Sundial Growers’s stock is valued at $0.35 at 17:32 EST, way below its 52-week high of $1.49 and above its 52-week low of $0.34.

Sundial Growers’s Moving Average

Sundial Growers’s value is way below its 50-day moving average of $0.54 and way below its 200-day moving average of $0.62.

More news about Sundial Growers.

10. Tesla (TSLA) – 10.62%

Tesla, Inc. develops, produces, leases, sells, leases, repairs, maintains, and services electric cars in America, China, Norway, the Netherlands, Norway, China, China, Norway, and worldwide. There are two main segments to the company: Automotive and Energy Generation and Storage. It offers both sedans as well as sport utility vehicles in the Automotive segment. The Automotive segment also offers electric powertrain components, systems, and services for electric cars through company-owned service points and Tesla mobile technicians. It also sells used vehicles. The segment sells and markets its products via a network company-owned galleries and stores, and its website. Energy Generation and Storage sells energy storage products such as rechargeable lithium ion batteries for homes, businesses, and utilities. They also design, manufacture, maintain, lease, and sell solar energy generation and storage products to commercial and residential customers. The company also offers vehicle insurance and renewable energy services. The former name of the company was Tesla Motors, Inc., but it changed its name in February 2017 to Tesla, Inc. Tesla, Inc. was established in 2003. Its headquarters are in Palo Alto, California.

NASDAQ ended the session with Tesla rising 10.62% to $719.35 on Tuesday, following the last session’s upward trend. NASDAQ jumped 2.51% to $11,069.30, following the last session’s upward trend on what was an all-around bullish trend exchanging session today.

Volume

Today’s last reported volume for Tesla is 36377200 which is 26.67% above its average volume of 28717100.

Tesla’s last close was $650.28, 47.71% below its 52-week high of $1,243.49.

News about Tesla today

  • Tesla (tsla) stock price and forecast: musk plans to cut 10% of salaried staff. According to today’s article on FXStreet, "This has forced Tesla to raise starting salaries by as much as 20% in order to reach hiring goals. ", "It’s pretty shocking that Tesla would just blatantly violate federal labor law by laying off so many workers without providing the required notice," said attorney for the workers Shannon Liss-Riordan in an interview with Reuters. "

The company’s growth estimates for the present quarter and the next is 54.5% and 71.5%, respectively.

Tesla’s Revenue

Year-on-year quarterly revenue growth grew by 80.5%, now sitting on 62.19B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Tesla’s stock is considered to be overbought (>=80).

Tesla’s Stock Yearly Top and Bottom Value

Tesla’s stock is valued at $719.35 at 17:32 EST, way under its 52-week high of $1,243.49 and way above its 52-week low of $608.88.

Tesla’s Moving Average

Tesla’s value is way under its 50-day moving average of $815.00 and way below its 200-day moving average of $912.72.

More news about Tesla.

Most Active Losers Today

1. Mesa Royalty Trust (MTR) – -14.51%

Mesa Royalty Trust holds net overriding royalties interests in several oil-and gas producing properties across the United States. It holds interests in property located in Kansas’ Hugoton and New Mexico’s San Juan Basin fields. Houston is the headquarters of this company, which was established in 1979.

NYSE ended the session with Mesa Royalty Trust falling 14.51% to $14.96 on Tuesday, after two sequential sessions in a row of losses. NYSE jumped 2.25% to $14,414.25, after two successive sessions in a row of losses, on what was an all-around bullish trend trading session today.

Volume

Today’s last reported volume for Mesa Royalty Trust is 52011 which is 1.68% above its average volume of 51148.

Mesa Royalty Trust’s last close was $14.96, 46.57% under its 52-week high of $28.00.

Mesa Royalty Trust’s Revenue

Year-on-year quarterly revenue growth grew by 115.5%, now sitting on 908.28k for the twelve trailing months.

Mesa Royalty Trust’s Stock Yearly Top and Bottom Value

Mesa Royalty Trust’s stock is valued at $14.96 at 17:32 EST, way under its 52-week high of $28.00 and way above its 52-week low of $5.20.

Mesa Royalty Trust’s Moving Average

Mesa Royalty Trust’s value is under its 50-day moving average of $15.07 and way above its 200-day moving average of $8.92.

More news about Mesa Royalty Trust.

2. Ecopetrol S.A. (EC) – -10.93%

Ecopetrol S.A. is an integrated oil-and gas company. It operates in three segments: Exploration and Production; Transport and Logistics; and the Refining and Petrochemical and Biofuels segment. The company is involved in exploration, production and sale of oil & gas. The company also distributes and transports hydrocarbons. The company owned approximately 9.106 km of crude oil pipelines and multi-purpose pipes as of December 31, 2019. The company also manufactures and sells polypropylene compounds and masterbatches, and refined and petrochemical product, biofuels, and industrial services to its customers. The company has offices in Colombia, Americas, Asia, Central America, the Caribbean, Europe and South America. Ecopetrol S.A. is a member of the Occidental Petroleum Corporation strategic alliance. The former name of the company was Empresa Colombiana de PetrA3leos. In June 2003, Ecopetrol S.A. took over. Ecopetrol S.A. is located in BogotA! in Colombia. It was established in 1948.

NYSE ended the session with Ecopetrol S.A. falling 10.93% to $12.19 on Tuesday while NYSE jumped 2.25% to $14,414.25.

Volume

Today’s last reported volume for Ecopetrol S.A. is 4358090 which is 227.97% above its average volume of 1328790.

Ecopetrol S.A.’s last close was $13.68, 14.02% below its 52-week high of $15.91.

Ecopetrol S.A.’s Sales

Ecopetrol S.A.’s sales growth is 75.8% for the present quarter and 53% for the next. The company’s growth estimates for the current quarter and the next is 454.5% and 600%, respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Ecopetrol S.A.’s stock is considered to be overbought (>=80).

Ecopetrol S.A.’s Stock Yearly Top and Bottom Value

Ecopetrol S.A.’s stock is valued at $12.19 at 17:32 EST, way under its 52-week high of $15.91 and above its 52-week low of $11.37.

Ecopetrol S.A.’s Moving Average

Ecopetrol S.A.’s value is way below its 50-day moving average of $14.56 and under its 200-day moving average of $13.53.

More news about Ecopetrol S.A..

3. MV Oil Trust Units of Beneficial Interests (MVO) – -9.51%

MV Oil Trust purchases and retains net profits in the natural gas and oil properties owned by MV Partners, LLC. The properties of MV Oil Trust include around 900 oil- and gas-producing wells in Kansas and Colorado’s Mid-Continent region. Houston is the headquarters of this company, which was established in 2006.

NYSE ended the session with MV Oil Trust Units of Beneficial Interests falling 9.51% to $9.32 on Tuesday, after five sequential sessions in a row of losses. NYSE rose 2.25% to $14,414.25, after two sequential sessions in a row of losses, on what was an all-around positive trend exchanging session today.

Volume

Today’s last reported volume for MV Oil Trust Units of Beneficial Interests is 148828 which is 74.22% above its average volume of 85422.

MV Oil Trust Units of Beneficial Interests’s last close was $9.32, 38.44% under its 52-week high of $15.14.

MV Oil Trust Units of Beneficial Interests’s Revenue

Year-on-year quarterly revenue growth grew by 283.2%, now sitting on 15.84M for the twelve trailing months.

MV Oil Trust Units of Beneficial Interests’s Stock Yearly Top and Bottom Value

MV Oil Trust Units of Beneficial Interests’s stock is valued at $9.32 at 17:32 EST, way below its 52-week high of $15.14 and way higher than its 52-week low of $5.56.

MV Oil Trust Units of Beneficial Interests’s Moving Average

MV Oil Trust Units of Beneficial Interests’s value is way under its 50-day moving average of $11.06 and below its 200-day moving average of $9.67.

More news about MV Oil Trust Units of Beneficial Interests.

4. Laredo Petroleum (LPI) – -8.74%

Laredo Petroleum, Inc., a separate energy company, is involved in the acquisition, exploration, development, and maintenance of natural gas properties within the Permian basin of West Texas, USA. It also operates natural gas lift stations and engages in other midstream activities. These include transportation, marketing, handling fresh, recycled and produced water as well as transporting and marketing oil and natural gases. It had accumulated 133,512 acres of Permian Basin land as of December 31, 2019 and total proven reserves of 293,377 million barrels of crude oil equivalent. It was previously known as Laredo Petroleum, Inc., but changed its name in December 2013 to Laredo Petroleum, Inc. Laredo Petroleum, Inc. was established in 2006. It is located in Tulsa, Oklahoma.

NYSE ended the session with Laredo Petroleum dropping 8.74% to $81.47 on Tuesday, after three sequential sessions in a row of losses. NYSE rose 2.25% to $14,414.25, after two consecutive sessions in a row of losses, on what was an all-around bullish trend exchanging session today.

Volume

Today’s last reported volume for Laredo Petroleum is 1931770 which is 126.6% above its average volume of 852476.

Laredo Petroleum’s last close was $81.47, 32.59% below its 52-week high of $120.86.

Laredo Petroleum’s Sales

Laredo Petroleum’s sales growth is 87.2% for the present quarter and 42% for the next. The company’s growth estimates for the current quarter and the next is 358.5% and 338.6%, respectively.

Laredo Petroleum’s Revenue

Year-on-year quarterly revenue growth grew by 150%, now sitting on 1.39B for the twelve trailing months.

Laredo Petroleum’s Stock Yearly Top and Bottom Value

Laredo Petroleum’s stock is valued at $81.47 at 17:32 EST, way under its 52-week high of $120.86 and way above its 52-week low of $36.25.

Laredo Petroleum’s Moving Average

Laredo Petroleum’s worth is higher than its 50-day moving average of $80.67 and way above its 200-day moving average of $74.01.

More news about Laredo Petroleum.

5. Fresenius Medical Care AG (FMS) – -8.64%

Fresenius Medical Care AG & Co. KGaA is a company that provides kidney dialysis services and related services. It also offers other healthcare services internationally. Fresenius Medical Care AG & Co. KGaA provides dialysis and other laboratory and diagnostic services via a network outpatient dialysis centers. Materials, training and support services include clinical monitoring and follow-up assistance. It also offers dialysis services to contract hospitals in the United States to patients with acute renal failure and patients with end-stage renal disease (ESRD). It also produces, distributes and manufactures dialysis equipment, including hemodialysis machines and peritoneal cycles, dialyzers and peritoneal solutions. It also develops, acquires and in-licenses kidney pharmaceuticals. The company offers supplies and medications to patients at home or in dialysis clinics. It sells products directly to hospitals and dialysis centers, as well through independent distributors and dealers and local agents. It had 3,994 dialysis centers in 150 countries as of December 31, 2019. Fresenius Medical Care AG & Co. KGaA is a German company that was founded in 1996. Its headquarters are in Bad Homburg.

NYSE ended the session with Fresenius Medical Care AG sliding 8.64% to $23.57 on Tuesday, after four successive sessions in a row of losses. NYSE rose 2.25% to $14,414.25, after two sequential sessions in a row of losses, on what was an all-around bullish trend exchanging session today.

Volume

Today’s last reported volume for Fresenius Medical Care AG is 3700050 which is 639.46% above its average volume of 500367.

Fresenius Medical Care AG’s last close was $25.80, 40.46% below its 52-week high of $43.33.

Fresenius Medical Care AG’s Sales

Fresenius Medical Care AG’s sales growth is a negative 5% for the current quarter and 27.6% for the next. The company’s growth estimates for the current quarter and the next is a negative 26% and a negative 24.7%, respectively.

Fresenius Medical Care AG’s Revenue

Year-on-year quarterly revenue growth declined by 5.2%, now sitting on 17.34B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Fresenius Medical Care AG’s stock is considered to be overbought (>=80).

Fresenius Medical Care AG’s Stock Yearly Top and Bottom Value

Fresenius Medical Care AG’s stock is valued at $23.57 at 17:33 EST, way under its 52-week low of $29.71.

Fresenius Medical Care AG’s Moving Average

Fresenius Medical Care AG’s value is way under its 50-day moving average of $33.36 and way under its 200-day moving average of $37.59.

More news about Fresenius Medical Care AG.

6. Matador Resources Company (MTDR) – -8.64%

Matador Resources Company is an independent energy company that specializes in exploration, development and production of natural gas and oil resources in the United States. The company operates through two distinct segments: Exploration and Production and Midstream. It holds interests in Wolfcamp and Bone Spring, which are located in Southeast New Mexico and West Texas. The company also owns the Eagle Ford Shale play in South Texas, and the Haynesville and Cotton Valley plays of Northwest Louisiana. The company also conducts middlestream operations to support its exploration, development and production operations. It provides oil processing and oil transport services. Additionally, it offers oil, saltwater gathering and natural gas services as well as services for salt water disposal. Its total proven oil and natural gas resources were estimated at 252.5 million barrels. This includes 148.0 million stock tanks barrels and 627.2 million cubic feet natural gas. The original name of the company was Matador Holdco, Inc., but it changed its name in August 2011 to Matador Resources Company. Matador Resources Company was established in 2003. It is located in Dallas, Texas.

NYSE ended the session with Matador Resources Company falling 8.64% to $51.20 on Tuesday, after three consecutive sessions in a row of losses. NYSE rose 2.25% to $14,414.25, after two successive sessions in a row of losses, on what was an all-around up trend trading session today.

Volume

Today’s last reported volume for Matador Resources Company is 4289360 which is 95.33% above its average volume of 2195850.

Matador Resources Company’s last close was $51.20, 24.46% below its 52-week high of $67.78.

Matador Resources Company’s Sales

Matador Resources Company’s sales growth is 125% for the current quarter and 88.5% for the next. The company’s growth estimates for the current quarter and the next is 203.9% and 126.4%, respectively.

Matador Resources Company’s Revenue

Year-on-year quarterly revenue growth grew by 96.6%, now sitting on 2.03B for the twelve trailing months.

Matador Resources Company’s Stock Yearly Top and Bottom Value

Matador Resources Company’s stock is valued at $51.20 at 17:33 EST, way under its 52-week high of $67.78 and way above its 52-week low of $24.76.

Matador Resources Company’s Moving Average

Matador Resources Company’s value is below its 50-day moving average of $55.15 and way higher than its 200-day moving average of $45.78.

More news about Matador Resources Company.

7. McEwen Mining (MUX) – -7.95%

McEwen Mining Inc. is engaged in exploration, development and production of silver and gold in the United States and Canada. It also explores for copper reserves. The company holds 100% of the El Gallo and Fenix Mexican projects; and the Black Fox Mine and Stock Mill and Grey Fox properties in Canada. It also holds interests in Canada’s Fuller, Davidson-Tisdale and Buffalo Ankerite exploration properties; as well as a 49% stake in San JosA(c), an Argentine mine. It also owns 100% of the Gold Bar, Tonkin, and San JosA(c) properties in Eureka County in Nevada. Additionally, the company has interests in Los Azules, an argentine copper project, located in San Juan’s cordilleran region. McEwen Mining Inc. was previously known as US Gold Corporation. McEwen Mining Inc. is located in Toronto, Canada. It was established in 1979.

NYSE ended the session with McEwen Mining falling 7.95% to $0.50 on Tuesday, following the last session’s downward trend. NYSE jumped 2.25% to $14,414.25, after two sequential sessions in a row of losses, on what was an all-around up trend trading session today.

Volume

Today’s last reported volume for McEwen Mining is 2862010 which is 43.52% above its average volume of 1994060.

McEwen Mining’s last close was $0.50, 66.91% under its 52-week high of $1.51.

McEwen Mining’s Revenue

Year-on-year quarterly revenue growth grew by 26.2%, now sitting on 136.54M for the twelve trailing months.

McEwen Mining’s Stock Yearly Top and Bottom Value

McEwen Mining’s stock is valued at $0.50 at 17:33 EST, way under its 52-week high of $1.51 and above its 52-week low of $0.46.

McEwen Mining’s Moving Average

McEwen Mining’s value is way below its 50-day moving average of $0.63 and way below its 200-day moving average of $0.89.

More news about McEwen Mining.

8. Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (LND) – -7.34%

BrasilAgro – Companhia Brasileira de Propriedades AgrAcolas is involved in the development, exploration and sale of land suitable for agriculture in Brazil. Six segments make up the company: Real Estate and Grains, Sugarcane and Cattle Raising. The company is involved with the production of cattle calves and their sale after they are weaned. It has 10 farms located in six Brazilian states, and one farm in Paraguay. The total land area is 215,330 ha of its own land and 53 7,355 ha of leased land. The company also exports and imports agricultural products, inputs; buys, rents and/or leases real estate, land, buildings and properties in urban and rural areas. It provides brokerage services and management of third-party assets. It was founded in Brazil in 2005. The headquarters are in Sao Paulo.

NYSE ended the session with Brasilagro Brazilian Agric Real Estate Co Sponsored ADR falling 7.34% to $5.43 on Tuesday, following the last session’s downward trend. NYSE rose 2.25% to $14,414.25, after two successive sessions in a row of losses, on what was an all-around positive trend exchanging session today.

Volume

Today’s last reported volume for Brasilagro Brazilian Agric Real Estate Co Sponsored ADR is 73107 which is 38.92% below its average volume of 119706.

Brasilagro Brazilian Agric Real Estate Co Sponsored ADR’s last close was $5.43, 44.7% under its 52-week high of $9.82.

Brasilagro Brazilian Agric Real Estate Co Sponsored ADR’s Revenue

Year-on-year quarterly revenue growth grew by 332.9%, now sitting on 1.26B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Brasilagro Brazilian Agric Real Estate Co Sponsored ADR’s stock is considered to be overbought (>=80).

Brasilagro Brazilian Agric Real Estate Co Sponsored ADR’s Stock Yearly Top and Bottom Value

Brasilagro Brazilian Agric Real Estate Co Sponsored ADR’s stock is valued at $5.43 at 17:33 EST, way under its 52-week high of $9.82 and way above its 52-week low of $4.26.

Brasilagro Brazilian Agric Real Estate Co Sponsored ADR’s Moving Average

Brasilagro Brazilian Agric Real Estate Co Sponsored ADR’s worth is way under its 50-day moving average of $6.64 and below its 200-day moving average of $5.81.

More news about Brasilagro Brazilian Agric Real Estate Co Sponsored ADR.

9. Ebix (EBIX) – -5.66%

Ebix, Inc. offers a range of ecommerce and software services to the insurance, financial, healthcare, education and other industries. It develops and deploys insurance and reinsurance exchanges; provides Software-as-a-Service (SaaS) enterprise solutions in the area of customer relationship management, and front-end and back-end systems; and offers outsourced administrative and risk compliance solutions. It operates P&C Exchanges in Australia, New Zealand and the United States. This facilitates insurance data exchange between insurance brokers and carriers, with a particular focus on personal and business lines. The company’s exchange-related products and services are travel exchanges, money transfer, foreign exchange, outward remittance, consumer bill payment, gift cards that consumers can redeem at different merchants, as well as technology services to various providers in areas such lending, wealth, asset management, logistics, and travel. SaaS platform, related services, licensing of software, and professional services that include setting up, customizing, training or consulting are some examples of the company’s insurance exchanges products and services. The company offers risk compliance solutions, certificates of insurance creation, tracking, consulting services that include project management and development, as well as business process outsourcing, which includes domain-intensive project management, time and material-based consulting engagements. Ebix, Inc. is a partner in a strategic partnership with Data Glove Technologies. The company used to be known as Delphi Systems, Inc. but changed its name in December 2003 to Ebix, Inc. Ebix, Inc. was established in 1976. It is located in Johns Creek, Georgia.

NASDAQ ended the session with Ebix dropping 5.66% to $15.69 on Tuesday while NASDAQ jumped 2.51% to $11,069.30.

Volume

Today’s last reported volume for Ebix is 1016920 which is 116.4% above its average volume of 469916.

Ebix’s last close was $16.63, 62.56% below its 52-week high of $44.42.

The company’s growth estimates for the present quarter and the next is 23.5% and 62%, respectively.

Ebix’s Revenue

Year-on-year quarterly revenue growth grew by 20.1%, now sitting on 994.94M for the twelve trailing months.

Ebix’s Stock Yearly Top and Bottom Value

Ebix’s stock is valued at $15.69 at 17:33 EST, way under its 52-week high of $44.42 and way higher than its 52-week low of $12.50.

Ebix’s Moving Average

Ebix’s worth is way under its 50-day moving average of $29.29 and way below its 200-day moving average of $30.64.

More news about Ebix.

10. Natural Grocers by Vitamin Cottage (NGVC) – -5.38%

Together with its affiliates, Natural Grocers by Vitamin Cottage, Inc. sells organic and natural groceries and dietary supplements throughout the United States. It sells organic and natural grocery products such as bulk foods, organic produce, private label, dry, frozen and canned groceries, meat and seafood, dairy products and dairy substitutes, eggs, prepared food, bread and baked goods, beverages, beer, wine and hard cider. The company’s retail stores sell private label dietary supplements, body care products that include cosmetics, skin and hair care products as well as personal care products. They also offer pet care and food products. Books and handouts are available. It operates retail stores under its Natural Grocers by Vitamin Cottage brand. It had 159 retail stores across 20 states as of June 4, 2020. Natural Grocers by Vitamin Cottage, Inc. is an American company that was established in Lakewood, Colorado in 1955.

NYSE ended the session with Natural Grocers by Vitamin Cottage falling 5.38% to $15.64 on Tuesday, after two consecutive sessions in a row of losses. NYSE jumped 2.25% to $14,414.25, after two successive sessions in a row of losses, on what was an all-around positive trend exchanging session today.

Volume

Today’s last reported volume for Natural Grocers by Vitamin Cottage is 69258 which is 23.29% below its average volume of 90296.

Natural Grocers by Vitamin Cottage’s last close was $15.64, 35.51% below its 52-week high of $24.25.

Natural Grocers by Vitamin Cottage’s Revenue

Year-on-year quarterly revenue growth grew by 4.6%, now sitting on 1.07B for the twelve trailing months.

Natural Grocers by Vitamin Cottage’s Stock Yearly Top and Bottom Value

Natural Grocers by Vitamin Cottage’s stock is valued at $15.64 at 17:33 EST, way below its 52-week high of $24.25 and way above its 52-week low of $9.88.

Natural Grocers by Vitamin Cottage’s Moving Average

Natural Grocers by Vitamin Cottage’s value is way below its 50-day moving average of $18.88 and higher than its 200-day moving average of $15.45.

More news about Natural Grocers by Vitamin Cottage.

Stay up to date with our winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here